期刊文献+

慢性乙型肝炎干扰素治疗前后血清β_2-微球蛋白的表达

The expression of the serum β2-MG after and before interferon-alpha in hepetitis B.
下载PDF
导出
摘要 对慢性乙型肝炎30例治疗前后及治疗期间用RIA法测定血清中β_2-微球蛋白(β_2-MG)水平及HBV标志。结果表明,在α-干扰素治疗前或治疗后血清中β_2-MG水平升高者疗效满意,相反则差。经统计学处理二者有明显差异(P<0.05)。因此认为,血清中β_2-MG表达水平有助于干扰素疗效的判定,并可作为一个间接指标。 Therapeutic effect and mechanism to interferon-alpha on 30 patients with hepatitis B virus inffection were studied.The level of serum β2-MG and HBV markers were measured after before and period of interferon-alpha therapy.The results show that highter level of serum β2-MG after or before of interferon-alpha therapy therapeutic effect were better than the lowers.The difference were statistically significant (P < 0.05).It's suggest that the level of expression in serum β2-MG will be helpful to judge of therapeutic effect of interferon-alpha and may as a indirect indication.
出处 《甘肃医药》 1995年第2期71-73,5,共3页 Gansu Medical Journal
关键词 乙型肝炎 干扰素 微球蛋白 治疗 HBV,interferon-alpha,β2 MG
  • 相关文献

参考文献2

  • 1叶维法,钟振义.肝病治疗学[M]天津科学技术出版社,1993.
  • 2Dr. Johnson Y. N. Lau MD,George L. A. Bird MD,Nikolai V. Naoumov MD,Roger Williams MD. Hepatic HLA antigen display in chronic hepatitis B virus infection[J] 1993,Digestive Diseases and Sciences(5):888~895

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部